THINK! SCIENCE - 28 JULY 2011
Products create value
A once R & D driven healthcare sector is now experiencing a fundamental shift as many players within the industry are focusing on marketable products. Wellington’s strategy reflects this trend, and it is paying off ... more»
Europe is the innovation leader
Rainer Strohmenger on the latest exit, the Wellington strategy, and the attractiveness of the European market
... more»
THINK! SCIENCE - 15 DECEMBER 2009
Rediscovery of success
New technologies, new methods of treatment, and new business models – after years of crisis the biotech industry is on its way to a spectacular comeback, made possible by returning to its main virtue: innovative strength ... more»
Biotech Is Back!
General Partner Thomas Widmann on the renaissance of a still young industry and its tremendous potential in a world with an aging population ... more»
THINK! SCIENCE - 08 JUNE 2009
Better treatment, lower costs
New medtech and diagnostic technologies are helping to improve patient benefits while reducing treatment costs – it’s a win-win situation for patients, doctors and payers ... more»
Higher efficiency will be the main driver
Wellington Partner Erich Schlick on progress in the medtech industry, Europe’s cutting edge and an award-winning therapeutics company ... more»
THINK! SCIENCE - 04 NOVEMBER 2008
Cancer loses its scare
New insights into the origins of cancers are helping in the development of improved methods for the early detection and treatment of cancer and precancerous tissue. That’s good news for patients, for tight healthcare budgets and for the young biotech and medtech companies that are working in this field ... more»
Venture capital is safe capital
Rainer Strohmenger on the impact of the financial crisis on our
industry and the prospects for young Life Sciences companies ... more» |
